Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Svenja Schneegans"'
Autor:
Svenja Schneegans, Jana Löptien, Angelika Mojzisch, Desirée Loreth, Oliver Kretz, Christoph Raschdorf, Annkathrin Hanssen, Antonia Gocke, Bente Siebels, Karthikeyan Gunasekaran, Yi Ding, Leticia Oliveira-Ferrer, Laura Brylka, Thorsten Schinke, Hartmut Schlüter, Ilkka Paatero, Hannah Voß, Stefan Werner, Klaus Pantel, Harriet Wikman
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 43, Iss 1, Pp 1-18 (2024)
Abstract Background Metastasis is the leading cause of cancer-related death in non-small cell lung cancer (NSCLC) patients. We previously showed that low HERC5 expression predicts early tumor dissemination and a dismal prognosis in NSCLC patients. He
Externí odkaz:
https://doaj.org/article/8ee82af4958b47ecbef81f24542bd06c
Autor:
Svenja Schneegans, Lelia Lück, Katharina Besler, Leonie Bluhm, Julia‐Christina Stadler, Janina Staub, Rüdiger Greinert, Beate Volkmer, Mikael Kubista, Christoffer Gebhardt, Alexander Sartori, Darryl Irwin, Elina Serkkola, Taija afHällström, Evi Lianidou, Markus Sprenger‐Haussels, Melanie Hussong, Peter Mohr, Stefan W. Schneider, Jonathan Shaffer, Klaus Pantel, Harriet Wikman
Publikováno v:
Molecular Oncology, Vol 14, Iss 5, Pp 1001-1015 (2020)
The combination of liquid biomarkers from a single blood tube can provide more comprehensive information on tumor development and progression in cancer patients compared to single analysis. Here, we evaluated whether a combined analysis of circulatin
Externí odkaz:
https://doaj.org/article/9e3df0b98bd64b93a6f200e8ad0438b0
Autor:
Desiree Loreth, Moritz Schuette, Jenny Zinke, Malte Mohme, Andras Piffko, Svenja Schneegans, Julia Stadler, Melanie Janning, Sonja Loges, Simon A. Joosse, Katrin Lamszus, Manfred Westphal, Volkmar Müller, Markus Glatzel, Jakob Matschke, Christoffer Gebhardt, Stefan W. Schneider, Iwona Belczacka, Beate Volkmer, Rüdiger Greinert, Marie-Laure Yaspo, Patrick N. Harter, Klaus Pantel, Harriet Wikman
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 13, p 6993 (2021)
Up to 40% of advance lung, melanoma and breast cancer patients suffer from brain metastases (BM) with increasing incidence. Here, we assessed whether circulating tumor cells (CTCs) in peripheral blood can serve as a disease surrogate, focusing on CD4
Externí odkaz:
https://doaj.org/article/16509b4c9bab441cbd41a1b4a6e22c5e
Autor:
Claudia Koch, Simon A. Joosse, Svenja Schneegans, Okka J. W. Wilken, Melanie Janning, Desiree Loreth, Volkmar Müller, Katharina Prieske, Malgorzata Banys-Paluchowski, Ludwig J. Horst, Sonja Loges, Sven Peine, Harriet Wikman, Tobias M. Gorges, Klaus Pantel
Publikováno v:
Cancers, Vol 12, Iss 2, p 442 (2020)
Circulating tumor cells (CTCs) are promising tools for risk prediction and the monitoring of response to therapy in cancer patients. Within the EU/IMI CANCER-ID consortium, we validated CTC enrichment systems for future inclusion into clinical trials
Externí odkaz:
https://doaj.org/article/6192b2aaf6f2446e937571ec02a10e8e
Autor:
Katharina Besler, Aleksandra Węglarz, Laura Keller, Gunhild von Amsberg, Natalia Bednarz-Knoll, Anne Offermann, Sara Stoupiec, Elke Eltze, Axel Semjonow, Lena Boettcher, Svenja Schneegans, Sven Perner, Siegfried Hauch, Tilman Todenhöfer, Sven Peine, Klaus Pantel, Harriet Wikman, Stefan Werner
Publikováno v:
Clinical Chemistry. 68:973-983
Background Revealing molecular mechanisms linked to androgen receptor activity can help to improve diagnosis and treatment of prostate cancer. Retinoic acid-induced 2 (RAI2) protein is thought to act as a transcriptional coregulator involved in hormo
Autor:
Peter Mohr, Klaus Pantel, Janina Staub, Harriet Wikman, Taija af Hällström, Julia-Christina Stadler, Stefan W. Schneider, Svenja Schneegans, Alexander Sartori, Evi Lianidou, Leonie Bluhm, Mikael Kubista, Jonathan M Shaffer, Darryl Irwin, Katharina Besler, Rüdiger Greinert, Elina Serkkola, Lelia Lück, Beate Volkmer, Christoffer Gebhardt, Melanie A. Hussong, Markus Sprenger-Haussels
Publikováno v:
Molecular Oncology, Vol 14, Iss 5, Pp 1001-1015 (2020)
Molecular Oncology
Molecular Oncology
The combination of liquid biomarkers from a single blood tube can provide more comprehensive information on tumor development and progression in cancer patients compared to single analysis. Here, we evaluated whether a combined analysis of circulatin
Autor:
Thorsten Schinke, Justine Münsterberg, Markus Glatzel, Monja Gandrass, Cecile L. Maire, Michaela Wrage, Katharina Besler, Stefan Steurer, Jakob Matschke, Jana Karbanová, Stefan Werner, Leticia Oliveira-Ferrer, Güntac Uzunoglu, Harriet Wikman, Denis Corbeil, Stefan W. Schneider, Katrin Lamszus, Jose Ramon Robador, Svenja Schneegans, Alexander Bauer, Andrea Kristina Horst, Yogesh K. Vashist, Desiree Loreth, Laura Brylka, Klaus Pantel, Fabienne Hamester
Publikováno v:
Neuro-Oncology. 22:955-966
Background Brain metastasis (BM) in non-small-cell lung cancer (NSCLC) has a very poor prognosis. Recent studies have demonstrated the importance of cell adhesion molecules in tumor metastasis. The aim of our study was to investigate the role of acti
Publikováno v:
Cell Reports. 40:111298
Circulating tumor cells (CTCs) are the seeds of distant metastasis, and the number of CTCs detected in the blood of cancer patients is associated with a worse prognosis. CTCs face critical challenges for their survival in circulation, such as anoikis
Autor:
Manfred Westphal, Markus Glatzel, Simon A. Joosse, Jenny Zinke, Melanie Janning, Malte Mohme, Harriet Wikman, Klaus Pantel, Julia T. Stadler, Moritz Schuette, Desiree Loreth, Volkmar Müller, Katrin Lamszus, Iwona Belczacka, Svenja Schneegans, Beate Volkmer, Andras Piffko, Marie-Laure Yaspo, Rüdiger Greinert, Jakob Matschke, Stefan W. Schneider, Sonja Loges, Patrick N. Harter, Christoffer Gebhardt
Publikováno v:
International Journal of Molecular Sciences
Volume 22
Issue 13
International Journal of Molecular Sciences, Vol 22, Iss 6993, p 6993 (2021)
Volume 22
Issue 13
International Journal of Molecular Sciences, Vol 22, Iss 6993, p 6993 (2021)
Up to 40% of advance lung, melanoma and breast cancer patients suffer from brain metastases (BM) with increasing incidence. Here, we assessed whether circulating tumor cells (CTCs) in peripheral blood can serve as a disease surrogate, focusing on CD4
Autor:
Ludwig J Horst, Svenja Schneegans, Malgorzata Banys-Paluchowski, Simon A. Joosse, Desiree Loreth, Klaus Pantel, Okka J. W. Wilken, Sonja Loges, Melanie Janning, Sven Peine, Tobias M. Gorges, Volkmar Müller, Harriet Wikman, Claudia Koch, Katharina Prieske
Publikováno v:
Cancers, Vol 12, Iss 2, p 442 (2020)
Cancers
Volume 12
Issue 2
Cancers
Volume 12
Issue 2
Circulating tumor cells (CTCs) are promising tools for risk prediction and the monitoring of response to therapy in cancer patients. Within the EU/IMI CANCER-ID consortium, we validated CTC enrichment systems for future inclusion into clinical trials